Automated Cell Cultures Market Analysis by Product (Consumables, and Equipment); by Application (Biopharmaceutical Production, Tissue Engineering & Regenerative Medicine, Drug Screening & Development, Gene Therapy, Stem Cell Research, Diagnostics, Toxicity Testing, and Others); and by End-User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, and Others)-Global Supply & Demand Analysis & Opportunity Outlook 2023-2033

  • Product Code:
    RP-ID-10059328
  • Published Date:
    28 Oct 2022
  • Region:
    Global
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-54

Impact Analysis on the Growth of Market

Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

..

..

The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Translate Report

Automated Cell Cultures Market Scope Report

 

 Base Year 

2022

Forecast Year

2023-2033

CAGR

~10%

Base Year Market Size (2022)

 ~ USD 12 Billion

Forecast Year Market Size (2033)

~ USD 27 Billion

 

Global Automated Cell Cultures Market Size, Forecast, and Trend Highlights Over 2023 - 2033

The global automated cell cultures market is estimated to garner a revenue of USD 27 billion by the end of 2033 by growing at a CAGR of ~10% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of USD 12 billion in the year 2022. The primary growth factor of the automated cell cultures market is increasing demand from pharmaceutical and medical device manufacturers. This increase in demand stems from the need to reduce development time for new drugs and devices, as well as lessen production costs. As per recent statistics, the pharmaceutical sector invested $83 billion in R&D in 2019. With a peak of 59 new pharmaceuticals approved in 2018, the number of new drugs approved for sale climbed by 60% in 2019 compared to the prior ten years.

 

Automated-Cell-Cultures-Market Industry Analysis

 

GET A SAMPLE COPY OF THIS REPORT

 

Although cellular tests are significantly less expensive than animal testing, cultured cells have been crucial to many scientific breakthroughs, and their usage in drug development is only growing. The upkeep of cells is typically a daily activity, and the burden increases as a laboratory use more cell lines, whether for short- or long-term studies. The bulk of cell culture efforts includes trypsinization of adherent cells and passage of those cells into a new vessel, as well as other components of sterile liquid handling. To make sure the culture is healthy and the necessary number of cells are taken forward or placed on a plate for use, cell viability and concentration must also be periodically and during passage evaluated. The typical procedures for maintaining cell lines seeding, feeding, passaging, and cell expansion must be made as efficient as possible. As per NCBI statistics, although the level of adhesion varies from cell line to cell line, trypsin is typically needed to release the cells from the flask. In all studied cell lines, trypsinized cells had a viability level of 80.17–2.8%.

Global Automated Cell Cultures Market: Growth Drivers and Challenges

Growth Drivers

  • Demand for 3D Cell Cultures is Rising – According to NCBI research, cells maintained in 3D models are more difficult to treat. For instance, paclitaxel therapy reduced ovarian cancer cell survival and proliferation in 3D cultures by 40% or 60% in 3D cell spheroids.

  • Demand for Cell Culture Technology in Vaccine Production is Growing – One of the most dangerous human pathogens and a major contributor to acute respiratory infections is the influenza virus. Each year, seasonal influenza affects between 10% and 30% of the population in the European Union, results in between 4 and 50 million symptomatic cases, and kills between 15,000 and 70,000 individuals. The three (trivalent) or four (quadrivalent) influenza virus strains are used in influenza vaccinations. According to recent statistics, the cell culture-based vaccination was given to 50% of people, 50% of whom were youngsters between the ages of 4 and 17.

  • Increasing Demand from the Food and Beverage Industry – To serve the expanding human population, a novel food source that is wholesome and sustainably produced is required. By the year 2050, it is predicted that there will be 10 billion people on the planet, and the current food system won't be able to supply everyone with wholesome food.

  • Increasing Prevalence of Infectious and Chronic Diseases – To prepare for an aging population, chronic illness management research and development has started to develop disease prevention and management technologies. As per recent statistics, 81% of all deaths are caused by chronic diseases (noninfectious diseases). Chronic diseases account for seven out of ten death causes.

Challenges

  • Automating Cell Culturing Require Expensive Equipment and Labor

  • Automation May Lead to Diminishing Returns

  • Regulatory Issues Related to Cellular Therapy Remain Unresolved

The global automated cell cultures market is segmented and analyzed for demand and supply by-product into consumables and equipment. Out of these, the consumables segment is expected to hold the largest share over the forecast period. This growing trend is driven by the increasing demand for products that contain specific types of cells or enzymes, which can be difficult or impossible to produce in large quantities using traditional methods. Almost all cell culture vessels, along with support supplies like tubes and pipettes, are offered in the marketplace in single-use, sterile packs. The simplest pipettes to use for cell culture are disposable plastic ones that come in 1ml, 2ml, 5ml, 10ml, and 25ml sizes. For instance, Serological pipettes are typically made of glass (non-disposable) or plastic and exist in a range of sizes, often from 0.5 ml to 25 ml (disposable). The majority of the time, we'll use disposable pipettes and a mechanical pipette pump.

Global Automated Cell Cultures Market Regional Synopsis

Regionally, the global automated cell cultures market is studied into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Amongst these, the market in the North America region is projected to hold the largest market share by the end of 2033. The rise in demand for customized medicine, the increase in R&D efforts for cancer and other chronic diseases, rising R&D spending, and the existence of key companies in the area are the main causes of the market expansion in the region. As per the National Cancer Institute (NCI) of the United States Department of Health and Human Services (National Institutes of Health) estimates that by the end of 2020, the NCI budget for funding cancer research will reach USD 6500 million.

Market Segmentation

Our in-depth analysis of the global automated cell cultures market includes the following segments:

By Product

  • Consumables

  • Equipment

By Application

  • Biopharmaceutical Production

  • Tissue Engineering & Regenerative Medicine

  • Drug Screening & Development

  • Gene Therapy

  • Stem Cell Research

  • Diagnostics

  • Toxicity Testing

  • Others

By End-User

  • Pharmaceutical & Biotechnology Companies

  • Hospitals & Diagnostic Laboratories

  • Research & Academic Institutions

  • Others

 
Customize this Report: Request Customization

Key Companies Dominating the Global Automated Cell Cultures Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global automated cell cultures market that are included in our report are Hitachi, Ltd., Thermo Fisher Scientific, Inc., Sartorius AG, Hamilton Company, F. Hoffmann-La Roche Ltd., Merck KGaA, Becton, Dickinson and Company, Cell Culture Company, LLC., Lonza Group, and others.

Global Automated Cell Cultures Market: Latest Developments

  • January, 2021: Hitachi, Ltd., said today that it has created a system that uses digital technologies to depict activities based on electric power generated from renewable energy by a building, piece of equipment, or service.

  • November, 2021: Thermo Fisher Scientific Inc., a global leader in providing scientific services, today unveiled innovative proteomics solutions and several co-marketing agreements with experts in the field. These developments will improve the throughput, comprehensiveness, and quality of proteomics workflows for uses like single-cell studies and translational research.

 

Key Reasons to Buy Our Report

  • The report covers a detailed analysis comprising market share attained by each market segment and its sub-segments.

  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis, and challenges that impact market growth.

  • The report includes detailed company profiles of the major players dominating the market.

  • We use effective research methodologies to calculate the market numbers and provide value-added assessments for overall growth.

  • We provide customized reports as per the client’s requirement helping them to see possible and unexpected challenges and unforeseen opportunities to help them reach their goal.  


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

FREQUENTLY ASKED QUESTIONS

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
  1. Hitachi Ltd. 
  2. Thermo Fisher Scientific Inc. 
  3. Sartorius AG 
  4. Hamilton Company F. 
  5. Hoffmann-La Roche Ltd. 
  6. Merck KGaA 
  7. Becton 
  8. Dickinson and Company 
  9. Cell Culture Company LLC. 
  10. Lonza Group and others.
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports

-->